Peptide Nanoparticles (PNPs) Technology Platform
Drug Delivery Platform
The foundation of Phoreus's offerings is its Peptide Nanoparticles (PNPs) platform. These are self-assembling nanostructures engineered to encapsulate a diverse range of therapeutic molecules, including small molecules, proteins, and nucleic acids, for improved transport and delivery within the body.
- Capable of encapsulating small molecules, proteins, nucleic acids, and peptides.
- Features a modular design that allows for targeted delivery, reducing off-target effects and toxicity.
- Demonstrates minimized immune responses compared to lipid-based carriers.
- Supports alternative administration routes such as buccal, transdermal, and pulmonary delivery.
Built for
Phoreus targets researchers and development teams within pharmaceutical and biotechnology companies.
